Mometasona Ciclum (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Ciclum, is a corticosteroid presented as a nasal spray for intranasal use. It reduces inflammation in the nasal passages and is indicated for allergic rhinitis and other nasal inflammatory conditions in adults and children.

GNH USA supplies Mometasona Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal mucosa.

- Seasonal allergic rhinitis: alleviates nasal congestion, itching and sneezing. - Perennial allergic rhinitis: provides sustained relief of nasal symptoms throughout the year. - Nasal polyps: reduces polyp size and improves nasal airflow. - Non‑allergic rhinitis: helps control nasal inflammation and congestion.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning - Headache - Epistaxis (nosebleed) - Unpleasant taste - Throat irritation - Cough

Serious or Rare Side Effects: - Nasal septal perforation - Vision changes such as cataract or glaucoma - Severe allergic reaction (anaphylaxis) - Suppression of adrenal function - Fungal infection of the nasal mucosa

Use of Mometasona Ciclum should follow medical guidance and consider patient‑specific factors.

- Use only as prescribed: follow the prescriber's instructions for frequency and duration. - Avoid spray contact with eyes: rinse with water if accidental. - Do not share device: risk of cross‑contamination. - Monitor for signs of infection: report persistent nasal bleeding or ulceration. - Assess risk in patients with uncontrolled diabetes or glaucoma: consult healthcare provider. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with other medicines that affect corticosteroid activity or nasal mucosa.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local exposure. - Antifungal azoles (e.g., itraconazole): potential increased glucocorticoid activity.

Moderate Interactions (Monitor Closely): - Nasal decongestant sprays: may increase local irritation. - Antihistamines: monitor overall symptom control. - Live attenuated vaccines: consider timing due to possible immunosuppression.